HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.3
  1. Home
  2. /Compound

[(3aS,4R,6aR)-2,3,3a,4,5,6a-hexahydrofuro[2,3-b]furan-4-yl] N-[(2S,3R)-4-[(4-aminophenyl)sulfonyl-(2-hydroxy-2-methylpropyl)amino]-3-hydroxy-1-phenylbutan-2-yl]carbamate

HCID 71748962
New reaction
Print

Completing data — refresh the page later to see the latest

Basic informationNames & identifiersPropertiesChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
1130635-75-4
Standard SMILES
CC(C)(O)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CO[C@H]2OCC[C@H]21)S(=O)(=O)c1ccc(N)cc1
InChIKey
XGXCRIIMIUNTCF-ARXROMJUSA-N
Molecular formula
C27H37N3O8S
Average molar mass
563.7 g/mol
Monoisotopic mass
563.23013632

Names & identifiers

Preferred name
[(3aS,4R,6aR)-2,3,3a,4,5,6a-hexahydrofuro[2,3-b]furan-4-yl] N-[(2S,3R)-4-[(4-aminophenyl)sulfonyl-(2-hydroxy-2-methylpropyl)amino]-3-hydroxy-1-phenylbutan-2-yl]carbamate
IUPAC
[(3aS,4R,6aR)-2,3,3a,4,5,6a-hexahydrofuro[2,3-b]furan-4-yl] N-[(2S,3R)-4-[(4-aminophenyl)sulfonyl-(2-hydroxy-2-methylpropyl)amino]-3-hydroxy-1-phenylbutan-2-yl]carbamate
English name
Hydroxy Darunavir
Molecular formula
C27H37N3O8S
Molecular weight
563.67

Names & synonyms

Darunavir metabolite M23US8D8UZX051130635-75-41809154-88-8UNII-US8D8UZX05R426857R-426857[(3aS,4R,6aR)-2,3,3a,4,5,6a-hexahydrofuro[2,3-b]furan-4-yl] N-[(2S,3R)-4-[(4-aminophenyl)sulfonyl-(2-hydroxy-2-methylpropyl)amino]-3-hydroxy-1-phenylbutan-2-yl]carbamateCarbamic acid, N-((1S,2R)-3-(((4-aminophenyl)sulfonyl)(2-hydroxy-2-methylpropyl)amino)-2-hydroxy-1-(phenylmethyl)propyl)-, (3R,3aS,6aR)-hexahydrofuro(2,3-b)furan-3-yl esterHydroxydarunavirN-[3-[[(4-aminophenyl)sulfonyl](2-hydroxy-2-methylpropyl)amino]-2-hydroxy-1-(phenylmethyl)propyl]carbamic Acid Hexahydrofuro[2,3-b]furan-3-yl Estermetabolite 23, R426857
Show more names
Hydroxy Darunavir
DTXSID20857750(3R,3aS,6aR)-Hexahydrofuro[2,3-b]furan-3-yl {(2S,3R)-4-[(4-aminobenzene-1-sulfonyl)(2-hydroxy-2-methylpropyl)amino]-3-hydroxy-1-phenylbutan-2-yl}carbamate(3R,3aS,6aR)-Hexahydrofuro[2,3-b]furan-3-yl {(2S,3R)-4-[4-amino-N-(2-hydroxy-2-methylpropyl)benzene-1-sulfonamido]-3-hydroxy-1-phenylbutan-2-yl}carbamateCarbamic acid, N-[3-[[(4-aminophenyl)sulfonyl](2-hydroxy-2-methylpropyl)amino]-2-hydroxy-1-(phenylmethyl)propyl]-, hexahydrofuro[2,3-b]furan-3-yl esterHexahydrofuro[2,3-b]furan-3-yl N-[3-[[(4-aminophenyl)sulfonyl](2-hydroxy-2-methylpropyl)amino]-2-hydroxy-1-(phenylmethyl)propyl]carbamate

Properties

Computed structural propertiesFilling in

XLogP
1.5
Topological polar surface area
169 Ų
Hydrogen bond donors
4
Hydrogen bond acceptors
10
Rotatable bonds
12
Heavy atoms
39
Formal charge
0
Complexity
899

Experimental & physicochemical properties

DrugsPharmaceuticals -> Metabolite of Darunavir

Physicochemical properties

Density
1.39 · 1.390±0.10 g/cm3(Temp: 25 °C; Press: 760 Torr)(predicted)
solubility
DMSO: solubleMethanol: soluble
pka
11.432 · 11.432±0.46(predicted)
FDA UNII
8 D8UZX05 · US8D8UZX05

Chemistry & industry

Applications

UsesA metabolite of Daranavir (D193500). It is a COVID19-related research product.

Related reactions

0 records
New reaction record
No related reactions yet

Compound notes

On this pageBasic informationNames & identifiersPropertiesChemistry & industryRelated reactionsCompound notes

Database identifiers

CAS
1130635-75-4、1809154-88-8
PubChem CID
71748962
DTXSID
DTXSID20857750
UNII
US8D8UZX05